Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Search content at Experts@Minnesota
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
New antipsychotic medications: More than old wine and new bottles
S. Charles Schulz
Psychiatry & Behavioral Sciences
Research output
:
Contribution to journal
›
Article
›
peer-review
5
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'New antipsychotic medications: More than old wine and new bottles'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Second-generation Antipsychotics
100%
Antipsychotic Medication
100%
Old Wine
100%
New Drugs
66%
Schizophrenia Treatment
66%
Medical Research Data
66%
United States
33%
Olanzapine
33%
Schizophrenia
33%
Risperidone
33%
Clozapine
33%
Mood Disorders
33%
Quetiapine
33%
Clinical Setting
33%
Pivotal Trial
33%
Movement Disorders
33%
Dosing Strategy
33%
Conduct Disorder
33%
Antipsychotic Prescriptions
33%
FDA Approval
33%
Pharmacology, Toxicology and Pharmaceutical Science
Antipsychotic
100%
Schizophrenia
75%
Clinical Research
50%
Mood Disorder
25%
Risperidone
25%
Olanzapine
25%
Quetiapine
25%
Clozapine
25%
Motor Dysfunction
25%
Conduct Disorder
25%
Side Effect
25%
Neuroscience
Antipsychotic
100%
Treatment of Schizophrenia
50%
Quetiapine
25%
Conduct Disorder
25%
Clozapine
25%
Olanzapine
25%
Risperidone
25%
Mood Disorder
25%
Stereotypic Movement Disorder
25%
Side Effect
25%
Schizophrenia
25%